Stockysis Logo
  • Login
  • Register
Back to News

AN2 Therapeutics Q1 EPS $(0.29) Misses $(0.23) Estimate

Benzinga Newsdesk www.benzinga.com Negative 64.6%
Neg 64.6% Neu 0% Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Terms of Service Contact Us